FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21516011000001101: Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71842101000001119 Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71842201000001114 Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Is a Oxycodone 5mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has AMP Candox 5mg modified-release tablets (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Candox 5mg modified-release tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start